Sissetulev dokumentAvalik
Kiri
Terviseamet · 13. november 2024
- Viit
- 11.1-2/24/11629-1
- Registreeritud
- 13. november 2024
- Dokumendi liik
- Sissetulev dokument
- Adressaat
- HAL Allergy B.V.
- Saabumis/saatmisviis
- e-post
- Funktsioon
- 11.1 SULETUD 2025 Turustamise järgne järelevalve (post-marketing surveillance)
- Sari
- 11.1-2 Kirjavahetus Eesti turule lastavatest/kasutusele võetavatest/levitatavatest seadmetest MSA kaudu teavitamiseks
- Toimik
- 11.1-2/2023
- Vastutaja
- Karl Kalev Türk (TA, Peadirektori asetäitja (1) vastutusvaldkond, Meditsiiniseadmete osakond)
Sisu (failidest)
Saatja: Driehuis, Ingelise <[email protected]>
Saaja: Meditsiiniseadmed (Medical Devices), Koster, Annette, '[email protected]'
Teema: import of prick test
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
Dear Mr Türk,
I would like to ask you some questions regarding a diagnostic (prick test) which HAL Allergy would like to import in Estonia:
1. HAL Allergy intends to sell a German registered and German labelled diagnostic (prick test) in Estonia. Is this allowed under Estonian law and, if so, on what legal basis? Could you please provide me with the English text of the relevant legislation?
1. Also, the leaflet for this diagnostic is currently in the German language. Is it required or allowed to provide our Estonian distributor by email with a translation of the official leaflet in the Estonian language (in pdf format), which the distributor can in turn provide (by email) to all customers (pharmacies, hospitals with a pharmacy)?
I appreciate receiving your swift answer.
Kind regards,
_________________________________________________________________________________________
[cid:[email protected]]
Ingelise Driehuis
Director Legal & Compliance Officer HQ
Phone: +31 (0) 88 1959 016 | Fax:+31 (0) 88 1959 001 | Mobile: +31 (0) 6 5798 7783
www.hal-allergy.com <http://www.hal-allergy.com>
HAL Allergy B.V. | J.H. Oortweg 15 | 2333 CH Leiden, The Netherlands
HAL Allergy Group
CEO: Alex Huybens, CCFO: Florian Rösch
[cid:[email protected]]<http://twitter.com/HAL_Allergy>[cid:[email protected]]<https://www.youtube.com/user/HALAllergy>[cid:[email protected]]<https://www.linkedin.com/company/hal-allergy?trk=biz-companies-cym>
This e-mail and any files transmitted with it may contain confidential information, and is solely intended for the addressee. If you have received this message in error, please notify the sender immediately by e-mail or telephone and delete the e-mail and any transmitted files without reading, copying or disclosing its contents to any other person. Any unauthorized disclosure of the contents of this e-mail and any files transmitted with it to other persons is prohibited. HAL Allergy Group does not accept any liability for unauthorized disclosure of the content of this e-mail and any transmitted files to third parties, mutilations to the content, or damage resulting from the use of the content of this e-mail and any transmitted files..